Inventor · disambiguated record
Alfred E. Slanetz
Also filed as: SLANETZ ALFRED E
2 granted patents·13 pending applications·63 citations·filing 1995–2023
60Inventor score
Top patents by PatentIndex Score
15 records- 0181US6080840ASoluble T cell receptorsFiled 1995·Granted Jun 27, 2000·63 cites·7 claims
- 0272US2024189353A1Modulated immunodominance therapyGENEIUS BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 0357US11723921B2Modulated immunodominance therapyGENEIUS BIOTECHNOLOGY INC·Filed 2017·Granted Aug 15, 2023·0 cites·12 claims
- 0452US2023145991A1T cell compositions for immunotherapyGENEIUS BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 0550US2014099341A1Modulated Immunodominance TherapySLANETZ ALFRED E·Filed 2012·Application pending·0 cites
- 0649US2009221436A1Process for determining target function and identifying drug leadsSLANETZ ALFRED E·Filed 2009·Application pending·0 cites
- 0749US2006234390A1Process for determining target function and identifying drug leadsSLANETZ ALFRED E·Filed 2003·Application pending·0 cites
- 0848US2017101625A1Modulated immunodominance therapyGENEIUS BIOTECHNOLOGY INC·Filed 2016·Application pending·0 cites
- 0948US2017042998A1Modulated immunodominance therapyGENEIUS BIOTECHNOLOGY INC·Filed 2016·Application pending·0 cites
- 1048US2017042999A1Modulated immunodominance therapyGENEIUS BIOTECHNOLOGY INC·Filed 2016·Application pending·0 cites
- 1148US2017043000A1Modulated immunodominance therapyGENEIUS BIOTECHNOLOGY INC·Filed 2016·Application pending·0 cites
- 1248US2017043001A1Modulated immunodominance therapyGENEIUS BIOTECHNOLOGY INC·Filed 2016·Application pending·0 cites
- 1341US2024000935A1Antigen specific t cells and methods of making and using sameGENEIUS BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 1441US2014012594A1Clinical Outcome-Dependent Medical Intervention Cost Reimbursement SystemSLANETZ ALFRED E·Filed 2011·Application pending·0 cites
- 1539US2020237819A1T cell compositions for immunotherapyGENEIUS BIOTECHNOLOGY INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alfred E. Slanetz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →